Premium
Drug‐Nutrient Interactions in Transplant Recipients
Author(s) -
Chan LingtakNeander
Publication year - 2001
Publication title -
journal of parenteral and enteral nutrition
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.935
H-Index - 98
eISSN - 1941-2444
pISSN - 0148-6071
DOI - 10.1177/0148607101025003132
Subject(s) - drug , medicine , nutrient , population , drug interaction , intensive care medicine , adverse effect , pharmacology , biology , environmental health , ecology
Drug‐nutrient interaction refers to an alteration of kinetics or dynamics of a drug or a nutritional element, or a compromise in nutritional status as a result of the addition of a drug. The potentials for drug—nutrient interaction increase with the number of drugs taken by the patient. Organ transplant recipients are therefore at high risk for drug‐nutrient interactions because multiple medications are used to manage graft rejection, opportunistic infections, and other associated complications. Unrecognized or unmanaged drug‐nutrient interactions in this patient population can have an adverse impact on their outcomes. This paper reviews the importance of recognizing drug‐nutrient interaction when using cyclosporine‐based regimens. (Journal of Parenteral and Enteral Nutrition 25: 132–141, 2001)